These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2006121)

  • 21. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.
    Davies BR; Barraclough R; Rudland PS
    Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
    Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.
    Ke Y; Beesley C; Smith P; Barraclough R; Rudland P; Foster CS
    Br J Cancer; 1998; 77(2):287-96. PubMed ID: 9461000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
    Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
    Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
    Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L
    Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.
    Burney TL; Rockove S; Eiseman JL; Jacobs SC; Kyprianou N
    Prostate; 1994 Oct; 25(4):177-88. PubMed ID: 8084835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No acquisition of metastatic capacity of R1H rhabdomyosarcoma upon transfection with c-Ha-ras oncogene.
    Baisch H; Collard J; Zywietz F; Jung H
    Invasion Metastasis; 1990; 10(4):193-207. PubMed ID: 2192992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel metastasis-suppressor region on human chromosome 12.
    Luu HH; Zagaja GP; Dubauskas Z; Chen SL; Smith RC; Watabe K; Ichikawa Y; Ichikawa T; Davis EM; Le Beau MM; Rinker-Schaeffer CW
    Cancer Res; 1998 Aug; 58(16):3561-5. PubMed ID: 9721861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.
    Lauri D; De Giovanni C; Biondelli T; Lalli E; Landuzzi L; Facchini A; Nicoletti G; Nanni P; Dejana E; Lollini PL
    Br J Cancer; 1993 Nov; 68(5):862-7. PubMed ID: 7692918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of the presence of adenovirus 5 E1a and E1b sequences on the pathology of rat embryonic fibroblasts transfected with activated c-Ha-ras and v-ras.
    Boghaert ER; Austin V; Zimmer SG
    Clin Exp Metastasis; 1991; 9(3):231-43. PubMed ID: 2060183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.
    Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA
    Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
    Schlatter B; Waghorne CG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.